Determining the Value of Disease Management Programs
- 1 September 2003
- journal article
- Published by Elsevier in The Joint Commission Journal on Quality and Safety
- Vol. 29 (9) , 491-499
- https://doi.org/10.1016/s1549-3741(03)29059-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Interventions used in disease management programmes for patients with chronic illness---which ones work? Meta-analysis of published reportsBMJ, 2002
- Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)Medical Decision Making, 2002
- Archimedes: a new model for simulating health care systems—the mathematical formulationJournal of Biomedical Informatics, 2002
- Improving Chronic Illness Care: Translating Evidence Into ActionHealth Affairs, 2001
- Impact of Long-Term Complications on Quality of Life in Patients with Type 2 Diabetes not Using InsulinValue in Health, 2001
- An economic analysis of interventions for diabetes.Diabetes Care, 2000
- Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.Diabetes Care, 1999
- Playing Disease Management Numbers GamesDisease Management and Health Outcomes, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Evaluating Costs, Benefits, and Return on Investment for Disease Management ProgramsDisease Management, 1998